PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28639216-0	2018	Biocomparison Study of Adult and Paediatric Dose Strengths of the Prostacyclin Receptor Agonist Selexipag.	selexipag	96-105	prostaglandin I2 receptor	Homo sapiens	66-87	
28639216-1	2018	BACKGROUND AND OBJECTIVES: Selexipag is an oral, non-prostanoid, selective prostacyclin receptor agonist recently marketed for the treatment of pulmonary arterial hypertension (PAH) in adults.	selexipag	27-36	prostaglandin I2 receptor	Homo sapiens	75-96